The University of Chicago Header Logo

IL-23 inhibitors for moderate-to-severe psoriasis.

IL-23 inhibitors for moderate-to-severe psoriasis. Semin Cutan Med Surg. 2018 Sep; 37(3):158-162.

View in: PubMed